Puniska Injectables Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 1.00 M
as on 16-11-2024
- Company Age 2 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 115.61 Cr
as on 16-11-2024
About Puniska Injectables
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹115.61 Cr.
The Key Managerial Personnel (KMP) at Puniska Injectables Private Limited India is Neha Verma as COMPANY SECRETARY. Kalpesh Patel, Manojkumar Jashwantlal, Punitaben Patel, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230GJ2022PTC132016
- Company No.
132016
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 May 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Puniska Injectables?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neha Verma  | Company Secretary | 15-Jun-2022 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manojkumar Jashwantlal | Director | 15-Jun-2022 | Current |
| Kalpesh Patel | Director | 14-May-2022 | Current |
| Punitaben Patel | Director | 14-May-2022 | Current |
| Maheshkumar Yadav | Director | 15-Jun-2022 | Current |
Financial Performance and Corporate Structure Insights of Puniska Injectables.
Puniska Injectables Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Puniska Injectables?
In 2023, Puniska Injectables had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pride Drugs And Pharma Private LimitedActive 19 years 4 monthsManojkumar Jashwantlal is a mutual person
- Puniska Industries Private LimitedActive 7 years 8 months
Kalpesh Patel, Manojkumar Jashwantlal and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 08 Sep 2022 | ₹115.61 Cr | Open |
How Many Employees Work at Puniska Injectables?
Puniska Injectables has a workforce of 281 employees as of Mar 26, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Puniska Injectables, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Puniska Injectables's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
